Cage Bio, Inc. — Form D/A
Cage Bio, Inc. of SAN CARLOS, CA, a company, filed a Form D amendment with the SEC on 2021-02-22. The offering totals $9.8M, of which $9.4M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-02-22
- Form: D/A
- Accession: 0001782671-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $9.8M
- Amount sold: $9.4M
- Remaining: $452K
- Investors: 56
- Date of first sale: 2019-06-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-344613
Issuer
- Name: Cage Bio, Inc.
- CIK: 0001782671
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 733 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070
- Phone: (650) 996 1845
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Ravi Srinivasan | Executive Officer | Southlake, TX |
| Nitin Joshi | Director | San Carlos, CA |
| Nitin Joshi | Executive Officer | San Carlos, CA |
| Jeff Keyser | Director | San Carlos, CA |
| Samir Mitragotri | Director | San Carlos, CA |
| Ravi Srinivasan | Director | Southlake, TX |
Other filings by this issuer (4)
More